Just a few weeks ago, Merck (known as MSD outside North America) paid $425 million to get hold of OncoImmune. The headline of the deal was an experimental COVID-19 drug, but it also claimed rights ...

AI leaders to urge senators to speed power supply permitting, boost government data access Microsoft and other AI leaders on Thursday will urge U.S. lawmakers to streamline federal permitting for ...